- Home
- APRE vs BMRA Comparison
APRE vs BMRA Comparison
Compare APRE & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- BMRA
- Stock Information
- Founded
- APRE 2006
- BMRA 1971
- Country
- APRE United States
- BMRA United States
- Employees
- APRE N/A
- BMRA N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- APRE Health Care
- BMRA Health Care
- Exchange
- APRE Nasdaq
- BMRA Nasdaq
- Market Cap
- APRE 9.7M
- BMRA 8.1M
- IPO Year
- APRE 2019
- BMRA N/A
- Fundamental
- Price
- APRE $1.75
- BMRA $3.38
- Analyst Decision
- APRE Strong Buy
- BMRA
- Analyst Count
- APRE 2
- BMRA 0
- Target Price
- APRE $15.50
- BMRA N/A
- AVG Volume (30 Days)
- APRE 35.9K
- BMRA 31.9K
- Earning Date
- APRE 05-14-2025
- BMRA 04-14-2025
- Dividend Yield
- APRE N/A
- BMRA N/A
- EPS Growth
- APRE N/A
- BMRA N/A
- EPS
- APRE N/A
- BMRA N/A
- Revenue
- APRE $1,284,475.00
- BMRA $5,678,000.00
- Revenue This Year
- APRE N/A
- BMRA N/A
- Revenue Next Year
- APRE N/A
- BMRA N/A
- P/E Ratio
- APRE N/A
- BMRA N/A
- Revenue Growth
- APRE 33.27
- BMRA 5.01
- 52 Week Low
- APRE $1.41
- BMRA $1.93
- 52 Week High
- APRE $5.01
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- APRE 49.51
- BMRA 47.71
- Support Level
- APRE $1.60
- BMRA $3.01
- Resistance Level
- APRE $2.00
- BMRA $3.28
- Average True Range (ATR)
- APRE 0.16
- BMRA 0.21
- MACD
- APRE 0.02
- BMRA 0.03
- Stochastic Oscillator
- APRE 37.50
- BMRA 57.58
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.